Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Driven by the downstream end-users, the market of Therapeutic Nuclear Medicines witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Therapeutic Nuclear Medicines market is offered. The research provides insights for the global Therapeutic Nuclear Medicines market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Therapeutic Nuclear Medicines industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Therapeutic Nuclear Medicines Market Segmentations:
By Players:
Lantheus Medical Imaging Inc.
Bayer AG
Cardinal Health Inc.
Mallinckrodt plc.
GE Healthcare
Bracco Imaging S.p.A
Nordion, Inc.
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Advanced Accelerator Applications S.A.
By Types:
Beta Emitters
Alpha Emitters
Brachytherapy Products
By End-User:
Hospitals
Ambulatory Surgical Centers
Radiology Clinics
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Reasons to Purchase the Therapeutic Nuclear Medicines Market Report
-
Vertical Market Divisions by Type and End-Users
-
The Most Promising Regions in the Forecast Period
-
Competitive Landscape
-
Key Players’ Strategies and Their Product Offerings
-
Therapeutic Nuclear Medicines Market Current Trends/Restraints/Challenges/Opportunities
-
Potential and Niche Market / Regions with Promising Growth
-
Objective Analysis Towards Market Performance
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Therapeutic Nuclear Medicines Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Therapeutic Nuclear Medicines Market Share by Types
1.3.2 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Beta Emitters from 2014 to 2026
1.3.3 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Alpha Emitters from 2014 to 2026
1.3.4 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Brachytherapy Products from 2014 to 2026
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Therapeutic Nuclear Medicines Market Share by End-Users
1.4.2 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.3 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
1.4.4 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Radiology Clinics from 2014 to 2026
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.1.1 United States Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.1.2 Canada Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.1.3 Mexico Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.1 Germany Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.2 UK Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.3 France Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.4 Italy Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.5 Nordic Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.6 Spain Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.7 BelgiumTherapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.8 Poland Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.9 Russia Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2.10 Turkey Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3.1 China Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3.2 Japan Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3.3 Australia and New Zealand Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3.4 India Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3.5 ASEAN Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3.6 South Korea Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4.1 GCC Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4.2 Brazil Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4.3 Nigeria Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4.4 South Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4.5 Argentina Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Therapeutic Nuclear Medicines Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Therapeutic Nuclear Medicines by Major Types
3.4.1 Market Size and Growth Rate of Beta Emitters
3.4.2 Market Size and Growth Rate of Alpha Emitters
3.4.3 Market Size and Growth Rate of Brachytherapy Products
4 Segmentation of Therapeutic Nuclear Medicines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Therapeutic Nuclear Medicines by Major End-Users
4.4.1 Market Size and Growth Rate of Therapeutic Nuclear Medicines for Hospitals
4.4.2 Market Size and Growth Rate of Therapeutic Nuclear Medicines for Ambulatory Surgical Centers
4.4.3 Market Size and Growth Rate of Therapeutic Nuclear Medicines for Radiology Clinics
5 Market Analysis by Major Regions
-
5.1 Global Therapeutic Nuclear Medicines Production Analysis by Major Regions
-
5.2 Global Therapeutic Nuclear Medicines Consumption Analysis by Major Regions
-
5.3 Global Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
6 Product Commodity of Therapeutic Nuclear Medicines Market in Major Countries
-
6.1 Top 5 Export Countries in Therapeutic Nuclear Medicines market from 2014 to 2019
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
6.2 Top 5 Import Countries in Therapeutic Nuclear Medicines market from 2014 to 2019
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Therapeutic Nuclear Medicines Landscape Analysis
-
7.1 North America Therapeutic Nuclear Medicines Landscape Analysis by Major Types
-
7.2 North America Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users
-
7.3 North America Therapeutic Nuclear Medicines Landscape Analysis by Major Countries
-
7.3.1 United States Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
7.3.2 Canada Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
7.3.3 Mexico Therapeutic Nuclear Medicines Market Volume and Growth Rate
8 Europe Therapeutic Nuclear Medicines Landscape Analysis
-
8.1 Europe Therapeutic Nuclear Medicines Landscape Analysis by Major Types
-
8.2 Europe Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users
-
8.3 Europe Therapeutic Nuclear Medicines Landscape Analysis by Major Countries
-
8.3.1 Germany Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.2 UK Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.3 France Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.4 Italy Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.5 Nordic Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.6 Spain Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.7 Belgium Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.8 Poland Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.9 Russia Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
8.3.10 Turkey Therapeutic Nuclear Medicines Market Volume and Growth Rate
9 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis
-
9.1 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis by Major Types
-
9.2 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis by Major Countries
-
9.3.1 China Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
9.3.2 Japan Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
9.3.4 India Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
9.3.6 South Korea Therapeutic Nuclear Medicines Market Volume and Growth Rate
10 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis
-
10.1 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
10.3.2 Brazil Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
10.3.3 Nigeria Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
10.3.4 South Africa Therapeutic Nuclear Medicines Market Volume and Growth Rate
-
10.3.5 Argentina Therapeutic Nuclear Medicines Market Volume and Growth Rate
11 Major Players Profile
11.1 Lantheus Medical Imaging Inc.
11.1.1 Lantheus Medical Imaging Inc. Company Profile and Development Status
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Bayer AG
11.2.1 Bayer AG Company Profile and Development Status
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 Cardinal Health Inc.
11.3.1 Cardinal Health Inc. Company Profile and Development Status
11.3.2 Market Performance
11.3.3 Product and Service Introduction
11.4 Mallinckrodt plc.
11.4.1 Mallinckrodt plc. Company Profile and Development Status
11.4.2 Market Performance
11.4.3 Product and Service Introduction
11.5 GE Healthcare
11.5.1 GE Healthcare Company Profile and Development Status
11.5.2 Market Performance
11.5.3 Product and Service Introduction
11.6 Bracco Imaging S.p.A
11.6.1 Bracco Imaging S.p.A Company Profile and Development Status
11.6.2 Market Performance
11.6.3 Product and Service Introduction
11.7 Nordion, Inc.
11.7.1 Nordion, Inc. Company Profile and Development Status
11.7.2 Market Performance
11.7.3 Product and Service Introduction
11.8 Eczacibasi-Monrol Nuclear Products
11.8.1 Eczacibasi-Monrol Nuclear Products Company Profile and Development Status
11.8.2 Market Performance
11.8.3 Product and Service Introduction
11.9 IBA Molecular Imaging
11.9.1 IBA Molecular Imaging Company Profile and Development Status
11.9.2 Market Performance
11.9.3 Product and Service Introduction
11.10 Advanced Accelerator Applications S.A.
11.10.1 Advanced Accelerator Applications S.A. Company Profile and Development Status
11.10.2 Market Performance
11.10.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 101 Figures and 158 Tables)
-
Figure Product Picture
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Beta Emitters from 2014 to 2026
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Alpha Emitters from 2014 to 2026
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Brachytherapy Products from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Radiology Clinics from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure North America Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure United States Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure UK Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure France Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure China Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Australia and New Zealand Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure India Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nigeria Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Therapeutic Nuclear Medicines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Therapeutic Nuclear Medicines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Therapeutic Nuclear Medicines by Different Types from 2014 to 2026
-
Table Consumption Share of Therapeutic Nuclear Medicines by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Beta Emitters
Figure Market Size and Growth Rate of Alpha Emitters
Figure Market Size and Growth Rate of Brachytherapy Products
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Therapeutic Nuclear Medicines by Different End-Users from 2014 to 2026
-
Table Consumption Share of Therapeutic Nuclear Medicines by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Hospitals
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
Figure Market Size and Growth Rate of Radiology Clinics
-
Table Global Therapeutic Nuclear Medicines Production by Major Regions
-
Table Global Therapeutic Nuclear Medicines Production Share by Major Regions
-
Figure Global Therapeutic Nuclear Medicines Production Share by Major Regions in 2014
-
Figure Global Therapeutic Nuclear Medicines Production Share by Major Regions in 2018
-
Figure Global Therapeutic Nuclear Medicines Production Share by Major Regions in 2026
-
Table Global Therapeutic Nuclear Medicines Consumption by Major Regions
-
Table Global Therapeutic Nuclear Medicines Consumption Share by Major Regions
-
Figure Global Therapeutic Nuclear Medicines Consumption Share by Major Regions in 2014
-
Figure Global Therapeutic Nuclear Medicines Consumption Share by Major Regions in 2018
-
Figure Global Therapeutic Nuclear Medicines Consumption Share by Major Regions in 2026
-
Table North America Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Europe Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table North America Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by Types in 2014
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by Types in 2018
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by Types in 2026
-
Table North America Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table North America Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table North America Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table North America Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure North America Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure United States Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table Europe Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by Types in 2014
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by Types in 2018
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by Types in 2026
-
Table Europe Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table Europe Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table Europe Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure Germany Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure France Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types in 2014
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types in 2018
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types in 2026
-
Table Asia Pacific Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table Asia Pacific Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure China Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia and New ZealandTherapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure India Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types in 2014
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types in 2026
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026
-
Figure GCC Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Nigeria Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Lantheus Medical Imaging Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging Inc.
Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging Inc.
Figure Revenue and Market Share Analysis of Lantheus Medical Imaging Inc.
Table Product and Service Introduction of Lantheus Medical Imaging Inc.
Table Company Profile and Development Status of Bayer AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
Figure Sales and Growth Rate Analysis of Bayer AG
Figure Revenue and Market Share Analysis of Bayer AG
Table Product and Service Introduction of Bayer AG
Table Company Profile and Development Status of Cardinal Health Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health Inc.
Figure Sales and Growth Rate Analysis of Cardinal Health Inc.
Figure Revenue and Market Share Analysis of Cardinal Health Inc.
Table Product and Service Introduction of Cardinal Health Inc.
Table Company Profile and Development Status of Mallinckrodt plc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt plc.
Figure Sales and Growth Rate Analysis of Mallinckrodt plc.
Figure Revenue and Market Share Analysis of Mallinckrodt plc.
Table Product and Service Introduction of Mallinckrodt plc.
Table Company Profile and Development Status of GE Healthcare
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare
Figure Sales and Growth Rate Analysis of GE Healthcare
Figure Revenue and Market Share Analysis of GE Healthcare
Table Product and Service Introduction of GE Healthcare
Table Company Profile and Development Status of Bracco Imaging S.p.A
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging S.p.A
Figure Sales and Growth Rate Analysis of Bracco Imaging S.p.A
Figure Revenue and Market Share Analysis of Bracco Imaging S.p.A
Table Product and Service Introduction of Bracco Imaging S.p.A
Table Company Profile and Development Status of Nordion, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion, Inc.
Figure Sales and Growth Rate Analysis of Nordion, Inc.
Figure Revenue and Market Share Analysis of Nordion, Inc.
Table Product and Service Introduction of Nordion, Inc.
Table Company Profile and Development Status of Eczacibasi-Monrol Nuclear Products
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eczacibasi-Monrol Nuclear Products
Figure Sales and Growth Rate Analysis of Eczacibasi-Monrol Nuclear Products
Figure Revenue and Market Share Analysis of Eczacibasi-Monrol Nuclear Products
Table Product and Service Introduction of Eczacibasi-Monrol Nuclear Products
Table Company Profile and Development Status of IBA Molecular Imaging
Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Molecular Imaging
Figure Sales and Growth Rate Analysis of IBA Molecular Imaging
Figure Revenue and Market Share Analysis of IBA Molecular Imaging
Table Product and Service Introduction of IBA Molecular Imaging
Table Company Profile and Development Status of Advanced Accelerator Applications S.A.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications S.A.
Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications S.A.
Figure Revenue and Market Share Analysis of Advanced Accelerator Applications S.A.
Table Product and Service Introduction of Advanced Accelerator Applications S.A.
-
